Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Maryamchik

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Archives of Pathology & Laboratory Medicine|February 27, 2020
Apixaban Does Not Interfere With Protein S or Activated Protein C Resistance (Factor V Leiden) Testing Using aPTT-Based MethodsElena Maryamchik, Elizabeth M Van Cott
Archives of Pathology & Laboratory Medicine|September 19, 2017
Rivaroxaban Causes Missed Diagnosis of Protein S Deficiency but Not of Activated Protein C Resistance (Factor V Leiden)Elena Maryamchik, Matthew W Rosenbaum, Elizabeth M Van Cott
International Journal of Surgical Pathology|March 14, 2018
Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation Producing HCG: A Case Report of a Diagnostic PitfallElena Maryamchik, Kirill A Lyapichev, Bradford Halliday, et al.
Journal of Cutaneous Pathology|April 11, 2017
Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis-A potential marker for histopathologic distinction from morpheaAndrea Primiani Moy, Elena Maryamchik, Olga V Nikolskaia, et al.
Cytometry. Part B, Clinical Cytometry|May 1, 2020
New directions in chimeric antigen receptor T cell [CAR-T] therapy and related flow cytometryElena Maryamchik, Kathleen Mary Ellen Gallagher, Frederic I Preffer, et al.
Cytotherapy|March 3, 2025
International Society for Cell & Gene Therapy Expanded Access Working Group position paper: key considerations to support equitable and ethical expanded access to investigational cell- and gene-based interventionsElena Maryamchik, Laertis Ikonomou, Beth E Roxland, et al.
Histopathology|June 4, 2019
Actinomyces in Crohn's-like appendicitisBela A Horvath, Elena Maryamchik, Gregory C Miller, et al.
Cytotherapy|June 15, 2023
A machine-learning model that incorporates CD45 surface expression predicts hematopoietic progenitor cell recovery after freeze-thawArwa Z Al-Riyami, Elena Maryamchik, Richard S Hanna, et al.
Cytotherapy|May 5, 2025
Shaping the future of cell and gene therapy workforce development: training of cell therapy processing personnel - perspectives from the International Society for Cell & Gene Therapy Lab Practices CommitteeElena Maryamchik, Ashley Krull, Yvette C Tanhehco, et al.
British Journal of Haematology|January 11, 2024
Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case reportBinni Kunvarjee, Gloria Paz Contreras Yametti, Amanda G Blouin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Archives of Pathology & Laboratory Medicine|February 27, 2020
Apixaban Does Not Interfere With Protein S or Activated Protein C Resistance (Factor V Leiden) Testing Using aPTT-Based MethodsElena Maryamchik, Elizabeth M Van Cott
Archives of Pathology & Laboratory Medicine|September 19, 2017
Rivaroxaban Causes Missed Diagnosis of Protein S Deficiency but Not of Activated Protein C Resistance (Factor V Leiden)Elena Maryamchik, Matthew W Rosenbaum, Elizabeth M Van Cott
International Journal of Surgical Pathology|March 14, 2018
Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation Producing HCG: A Case Report of a Diagnostic PitfallElena Maryamchik, Kirill A Lyapichev, Bradford Halliday, et al.
Journal of Cutaneous Pathology|April 11, 2017
Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis-A potential marker for histopathologic distinction from morpheaAndrea Primiani Moy, Elena Maryamchik, Olga V Nikolskaia, et al.
Cytometry. Part B, Clinical Cytometry|May 1, 2020
New directions in chimeric antigen receptor T cell [CAR-T] therapy and related flow cytometryElena Maryamchik, Kathleen Mary Ellen Gallagher, Frederic I Preffer, et al.
Cytotherapy|March 3, 2025
International Society for Cell & Gene Therapy Expanded Access Working Group position paper: key considerations to support equitable and ethical expanded access to investigational cell- and gene-based interventionsElena Maryamchik, Laertis Ikonomou, Beth E Roxland, et al.
Histopathology|June 4, 2019
Actinomyces in Crohn's-like appendicitisBela A Horvath, Elena Maryamchik, Gregory C Miller, et al.
Cytotherapy|June 15, 2023
A machine-learning model that incorporates CD45 surface expression predicts hematopoietic progenitor cell recovery after freeze-thawArwa Z Al-Riyami, Elena Maryamchik, Richard S Hanna, et al.
Cytotherapy|May 5, 2025
Shaping the future of cell and gene therapy workforce development: training of cell therapy processing personnel - perspectives from the International Society for Cell & Gene Therapy Lab Practices CommitteeElena Maryamchik, Ashley Krull, Yvette C Tanhehco, et al.
British Journal of Haematology|January 11, 2024
Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case reportBinni Kunvarjee, Gloria Paz Contreras Yametti, Amanda G Blouin, et al.
Pageof 2